These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 18209156)

  • 1. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials.
    Butturini G; Stocken DD; Wente MN; Jeekel H; Klinkenbijl JH; Bakkevold KE; Takada T; Amano H; Dervenis C; Bassi C; Büchler MW; Neoptolemos JP;
    Arch Surg; 2008 Jan; 143(1):75-83; discussion 83. PubMed ID: 18209156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
    Shrikhande SV; Kleeff J; Reiser C; Weitz J; Hinz U; Esposito I; Schmidt J; Friess H; Büchler MW
    Ann Surg Oncol; 2007 Jan; 14(1):118-27. PubMed ID: 17066229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
    Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
    Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival.
    Fatima J; Schnelldorfer T; Barton J; Wood CM; Wiste HJ; Smyrk TC; Zhang L; Sarr MG; Nagorney DM; Farnell MB
    Arch Surg; 2010 Feb; 145(2):167-72. PubMed ID: 20157085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
    Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
    Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival.
    Kato K; Yamada S; Sugimoto H; Kanazumi N; Nomoto S; Takeda S; Kodera Y; Morita S; Nakao A
    Pancreas; 2009 Aug; 38(6):605-12. PubMed ID: 19629002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative cytology for drained fluid from the pancreatic bed after "curative" resection of pancreatic cancers: does it predict both the patient's prognosis and the site of cancer recurrence?
    Ishikawa O; Wada H; Ohigashi H; Doki Y; Yokoyama S; Noura S; Yamada T; Sasaki Y; Imaoka S; Kasugai T; Matsunaga T; Takenaka A; Nakaizumi A
    Ann Surg; 2003 Jul; 238(1):103-10. PubMed ID: 12832972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases.
    Zhou GW; Wu WD; Xiao WD; Li HW; Peng CH
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):130-4. PubMed ID: 15730937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
    Ghaneh P; Neoptolemos JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
    Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
    Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Well or poorly differentiated nonfunctioning neuroendocrine carcinoma of the pancreas: a single institution experience with 17 cases.
    Sellner F; Sobhian B; De Santis M; Pont J; Staettner S; Sellner S; Karner J; Klimpfinger M
    Eur J Surg Oncol; 2008 Feb; 34(2):191-5. PubMed ID: 17475440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
    Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
    Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgery for pancreatic cancer].
    Welsch T; Büchler MW; Schmidt J
    Z Gastroenterol; 2008 Dec; 46(12):1393-403. PubMed ID: 19053009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ductal adenocarcinoma of the head of the pancreas: a critical study of R1 resection rates].
    Delpero JR; Turrini O
    Bull Cancer; 2008 Dec; 95(12):1193-8. PubMed ID: 19091653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
    Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
    Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.
    Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
    BMC Cancer; 2008 Jan; 8():5. PubMed ID: 18194510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cytokeratin-20 in pancreatic cancer: an indicator of poor outcome after R0 resection.
    Schmitz-Winnenthal FH; Volk C; Helmke B; Berger S; Hinz U; Koch M; Weitz J; Kleeff J; Friess H; Zöller M; Büchler MW; Z'graggen K
    Surgery; 2006 Jan; 139(1):104-8. PubMed ID: 16364723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
    Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
    Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data.
    Chau I; Norman AR; Cunningham D; Waters JS; Oates J; Ross PJ
    J Clin Oncol; 2004 Jun; 22(12):2395-403. PubMed ID: 15197201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.